{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-034922","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2024-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.346941+00:00","generated_at":"2026-05-30T00:51:17.016826+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DiaMedica updates AIS trial protocol, delays interim readout to Q4 2025; Q3 R&D spend rises","bullets":["Expanded ReMEDy2 trial to include thrombolytic non-responders; interim analysis sample size increased to 200 from 144.","Top-line interim results now expected Q4 2025 (prior Summer 2025); interim analysis delayed.","Q3 2024 R&D expenses $5.0M (up from $3.3M YoY); G&A flat at $1.9M.","Cash, equivalents and investments $50.2M as of Sep 30, 2024; cash runway into Q3 2026.","Preeclampsia Phase 2 IST received SAHPRA approval; first patient dosed; top-line Part 1A results expected H1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-034922","json":"https://secwatch.observer/filing/0001437749-24-034922.json","markdown":"https://secwatch.observer/filing/0001437749-24-034922.md","text":"https://secwatch.observer/filing/0001437749-24-034922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774924034922/0001437749-24-034922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774924034922/dmtp20241113_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:51:17.016826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}